wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48719101-ABA1CBE6-9006-4FCB-A380-70B03C57845A
Q48719101-ABA1CBE6-9006-4FCB-A380-70B03C57845A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48719101-ABA1CBE6-9006-4FCB-A380-70B03C57845A
Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective β3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?
P2860
Q48719101-ABA1CBE6-9006-4FCB-A380-70B03C57845A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48719101-ABA1CBE6-9006-4FCB-A380-70B03C57845A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74c2747710547eb571c5f425b74e4f0f6b7e8c6e
P2860
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.